首页 | 本学科首页   官方微博 | 高级检索  
     

慈丹胶囊在肝癌化疗放疗中的协同作用
引用本文:张新华,陈新国,李长青,杨自万. 慈丹胶囊在肝癌化疗放疗中的协同作用[J]. 中西医结合肝病杂志, 2000, 10(2): 7-8
作者姓名:张新华  陈新国  李长青  杨自万
作者单位:湖北省肿瘤医院,武汉,430070
摘    要:目的;观察中成药慈丹胶囊在肝癌化疗、放疗中的作用。方法:将54例经剖腹探查判定不可手术切除Ⅱ期的原发性肝癌分为两组,其中动脉化疗+放疗+慈 丹胶囊组29例(治疗A组),仅动脉化疗+放疗组25例(对照B组)。结果:治疗组肝区疼痛减轻率、腹胀减轻率、近期有效率、1年生存率分别为92%、89.3%、72.4%、93.1%,分别高于对照组,P均〈0.05。结论:慈丹胶囊与放疗、化疗并用,可望提高其疗效。

关 键 词:慈丹胶囊 肝癌 放疗化疗 协同作用 治疗
修稿时间:1999-12-08

Synergistic Action of Capsule Cidan during Chemotherapy and Radiotherapy of Liver Cancer
Zhang Xinhua,Chen Xinguo,Li Changqing,et al.. Synergistic Action of Capsule Cidan during Chemotherapy and Radiotherapy of Liver Cancer[J]. Chinese Journal of Integrated Traditonal and Western Medicine on Liver Diseases, 2000, 10(2): 7-8
Authors:Zhang Xinhua  Chen Xinguo  Li Changqing  et al.
Affiliation:Zhang Xinhua,Chen Xinguo,Li Changqing,et al. Hubei Cancer Hospital
Abstract:Aim: To observe the treatment effect of Capsule Cidan. one of Chinese patent medicine, during chemotherapy and radiotherapy of liver cancer. Method: Divided 54 cases of primary liver cancer patients which can't excise with operation decided with exploratory laparotomy into two group: A group contain 29 cases, B group contain 25 cases. A group with artery chemotherapy, radiotherapy and Capsule Cidan, whereas B group with only artery chemotherapy and radiotherapy. Result: The palliate rate of hepatalgia, windy and short-term effective rate, survival rate of one year of A group were 92% , 89. 3% , 72. 4% and 93. 1 % , respectively, and they were higher than that of B group, the P value were lower than 0. 05. Conclusion: Capsule Cidan can combine with rediotherapy and chemotherapy to improve its therapeutic effect.
Keywords:Capsule Cidan Liver Cancer Radiotherapy Chemotherapy Synergistic Action  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号